Ranitidine is an H2 histamine receptor antagonist historically utilized to treat gastroesophageal reflux disease and peptic ulcer disease by blocking histamine receptors to reduce gastric acid secretion.… Read more





![Chemical structure of 1,1'-N-[Methylenebis(sulphanediylethylene)]bis(N'-methyl-2-nitroethene-1,1-diamine-d6](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1331643-21-0-11-N-MethylenebissulphanediylethylenebisN-methyl-2-nitroethene-11-diamine-d6.png&w=3840&q=75)


![Chemical structure of 5,6-Dihydro-3-(methylamino)-2H-1,4-thiazin-2-one O-[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]oxime](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F112233-24-6-56-Dihydro-3-methylamino-2H-14-thiazin-2-one-O-5-Dimethylaminomethyl-2-furanylmethyloxime.png&w=3840&q=75)

![Chemical structure of 5-[(Dimethyl-d6-amino)methyl]-2-furanmethanol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1189683-82-6-5-Dimethyl-d6-aminomethyl-2-furanmethanol.png&w=3840&q=75)
![Chemical structure of 5-[[(2-Aminoethyl)thio]methyl]-N-methyl-2-furanmethanamine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F66356-54-5-5-2-Aminoethylthiomethyl-N-methyl-2-furanmethanamine.png&w=3840&q=75)






![Chemical structure of N,N,N-Trimethyl-5-[[[2-[[1-(methylamino)-2-nitroethenyl]amino]ethyl]thio]methyl]-2-furanmethanaminium iodide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F154018-75-4-NNN-Trimethyl-5-2-1-methylamino-2-nitroethenylaminoethylthiomethyl-2-furanmethanaminium-iodide.png&w=3840&q=75)
![Chemical structure of N,N-Dimethyl-5-[[[2-[[1-(methylthio)-2-nitroethenyl]amino]ethyl]thio]methyl]-2-furanmethanamine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F72115-14-1-NN-Dimethyl-5-2-1-methylthio-2-nitroethenylaminoethylthiomethyl-2-furanmethanamine.png&w=3840&q=75)

![Chemical structure of N-[1-({2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)thio]ethyl}amino)-2-nitrovinyl]-N-methylnitrosamine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-1-2-5-dimethylaminomethylfuran-2-ylmethylthioethylamino-2-nitrovinyl-N-methylnitrosamine.png&w=3840&q=75)



![Chemical structure of N-{2-[({5-[(Dimethylamino)methyl]furan-2-yl}methyl)thio]ethyl}-N-[1-(methylamino)-2-nitrovinyl]nitrosamine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-2-5-Dimethylaminomethylfuran-2-ylmethylthioethyl-N-1-methylamino-2-nitrovinylnitrosamine.png&w=3840&q=75)


















Ranitidine is an H2 histamine receptor antagonist historically utilized to treat gastroesophageal reflux disease and peptic ulcer disease by blocking histamine receptors to reduce gastric acid secretion. This category encompasses a comprehensive collection of Ranitidine reference standards, including pharmacopeial and non-pharmacopeial impurities, degradation products, process-related synthetic intermediates, nitrosamine contaminants, and stable isotope labelled compounds. Pharmaceutical laboratories rely on these materials for essential analytical tasks such as method validation, stability testing, and rigorous impurity profiling to ensure product safety and regulatory compliance. Whether performing routine quality control or navigating complex ICH guidelines for toxicological evaluation, researchers use these structurally characterized compounds to identify unknown peaks and verify the precision of chromatographic methods throughout the drug development lifecycle.